CLINICAL_TRIALS
research
· 2026-03-27
Clinical Trial Update: OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH
Summary
Recruitment is ongoing for the OPtilume BPH Catheter System intended to treat symptomatic benign prostatic hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Urotronic Inc. | Conditions: Benign Prostatic Hyperplasia | Status: RECRUITING